FP
GSK icon

Foundry Partners’s GSK GSK Stock Holding History

Foundry Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-392,496
Closed -$16M – 286
2024
Q3 		$16M Sell
392,496
-2,321
-0.6% -$95K 0.79% 31
2024
Q2 		$15.2M Buy
394,817
+66,098
+20% +$2.78M 0.82% 32
2024
Q1 		$14.1M Buy
328,719
+106,130
+48% +$4.38M 0.75% 37
2023
Q4 		$8.25M Sell
222,589
-27,560
-11% -$989K 0.5% 55
2023
Q3 		$9.07M Buy
+250,149
New +$8.88M 0.56% 48
2020
Q3 		– Sell
-207,796
Closed -$10.6M – 425
2020
Q2 		$10.6M Sell
207,796
-17,215
-8% -$883K 0.52% 62
2020
Q1 		$10.7M Buy
225,011
+840
+0.4% +$44.8K 0.6% 49
2019
Q4 		$13.2M Buy
+224,171
New +$12.5M 0.5% 66
2019
Q3 		– Sell
-268,396
Closed -$13.4M – 394
2019
Q2 		$13.4M Buy
268,396
+135,988
+103% +$6.82M 0.53% 58
2019
Q1 		$6.92M Buy
+132,408
New +$6.62M 0.28% 127
2018
Q2 		– Sell
-150,408
Closed -$7.35M – 393
2018
Q1 		$7.35M Sell
150,408
-320
-0.2% -$14.9K 0.31% 114
2017
Q4 		$6.68M Sell
150,728
-7,596
-5% -$351K 0.28% 130
2017
Q3 		$8.04M Buy
158,324
+16,652
+12% +$845K 0.32% 112
2017
Q2 		$7.64M Buy
+141,672
New +$7.55M 0.31% 115

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Foundry Partners's GSK Position: Q4 2024 in Review

Foundry Partners sold out of GSK (GSK) in Q4 2024, closing a stake of 392,496 shares — an estimated $16M sold.

Foundry Partners first reported a position in GSK in Q2 2017 and held it in 14 quarters. The position peaked at $16M in Q3 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Foundry Partners reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Foundry Partners sold 392,496 GSK shares in Q4 2024, an estimated $16M.
  • Foundry Partners first reported a position in GSK in Q2 2017 and held it in 14 quarters.
  • Foundry Partners's GSK position peaked at $16M in Q3 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Foundry Partners's 13F filing for Q4 2024, filed 12 Feb 2025.